Omega Fund Management’s Gossamer Bio GOSS Stock Holding History

Omega Fund Management’s Portfolio GOSS Stock Details GOSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,500,000	Closed	-$18M	–	18
2022 Q3	$18M	Hold	1,500,000	–	–	6.58%	5
2022 Q2	$12.6M	Sell	1,500,000 -1,664,835	-53%	-$12.9M	4.01%	9
2022 Q1	$27.5M	Hold	3,164,835	–	–	5.62%	6
2021 Q4	$35.8M	Sell	3,164,835 -155,773	-5%	-$1.85M	5.06%	6
2021 Q3	$41.7M	Hold	3,320,608	–	–	4.68%	6
2021 Q2	$27M	Hold	3,320,608	–	–	3.05%	6
2021 Q1	$30.7M	Hold	3,320,608	–	–	2.91%	8
2020 Q4	$32.1M	Hold	3,320,608	–	–	4.82%	6
2020 Q3	$41.2M	Hold	3,320,608	–	–	11.15%	3
2020 Q2	$43.2M	Sell	3,320,608 -955,118	-22%	-$12M	11.8%	3
2020 Q1	$43.4M	Sell	4,275,726 -1,843,619	-30%	-$24.1M	17.96%	3
2019 Q4	$95.6M	Sell	6,119,345 -433,771	-7%	-$8.74M	30.44%	1
2019 Q3	$110M	Sell	6,553,116 -400,300	-6%	-$7.96M	33.96%	1
2019 Q2	$154M	Hold	6,953,416	–	–	39.34%	1
2019 Q1	$151M	Buy	+6,953,416	New	+$145M	48.31%	1

Other funds holding GOSS

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

WAM

Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Omega Fund Management's GOSS Position: Q4 2022 in Review

Omega Fund Management sold out of Gossamer Bio (GOSS) in Q4 2022, closing a stake of 1,500,000 shares — an estimated $18M sold.

Omega Fund Management first reported a position in GOSS in Q1 2019 and held it in 15 quarters. The position peaked at $154M in Q2 2019. 120 funds tracked by Wall St. Rank hold GOSS as of Q4 2022.

Omega Fund Management reported no remaining Gossamer Bio position as of Q4 2022 after selling out during the quarter.
Omega Fund Management sold 1,500,000 Gossamer Bio shares in Q4 2022, an estimated $18M.
Omega Fund Management first reported a position in Gossamer Bio in Q1 2019 and held it in 15 quarters.
Omega Fund Management's Gossamer Bio position peaked at $154M in Q2 2019.
120 funds tracked by Wall St. Rank held Gossamer Bio as of Q4 2022.

Based on Omega Fund Management's 13F filing for Q4 2022, filed 13 Feb 2023.